The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

New KRAS G12C / MET Exon 14 TKI’s for Advanced NSCLC: Favorable Safety Profile and Promising Antitumor Activity of AMG 510 / Capmatinib and Bozitinib

430 views
November 12, 2019
Comments 0
Login to view comments. Click here to Login